Sitemap
October 09, 2017 Articles
Filter by Available Specialty
- 2 decades of HF
- A Conversation with Roxana Mehran, MD
- A discussion on generic pharmaceutical drugs from an intellectual property perspective
- A Diverse, Stimulating Agenda
- A Global Focus on Critical Limb Ischemia
- A look at CV effects of novel cancer therapies
- Aggressive breast cancer surgeries increase likelihood of missed work
- Amiodarone Toxicity
- Aortic Regurgitation - Physical Exam
- Ask the Experts: What Are You Looking Forward to Most at TCT 2017?
- Aspheric aberration-correcting IOL leads to enhanced visual acuity, depth of focus, contrast sensitivity
- Beyond LDL: CV experts working to combat residual lipid-related risk
- California law expands OD scope of practice
- Certified nursing assistants often fail to change gloves in long-term care facility
- Combined interferon therapy safe, tolerable in HBV/HDV coinfection
- Computer-assisted CBT effective for depression
- Crizotinib effectively targets ALK pathway in pediatric cancers
- Elevated inflammatory markers may predict hip fracture risk in older adults
- ESCRS Binkhorst Medal Lecture focuses on challenges of small-pupil cataract surgery
- ESCRS fosters education, curricula and international exchange
- Ethanol lock therapy ineffective at preventing, treating CLABSIs
- Exhibit Hall Listing for TCT 2017
- Families of children treated with ECMO report certain favorable outcomes
- FDA grants breakthrough therapy designation to Tagrisso for EGFR-positive non-small cell lung cancer
- FDA grants orphan drug designation to PCM-075 for acute myeloid leukemia
- First Report Investigations
- Future Directions: Projections for the Coming Years
- Glistening-free hydrophobic IOL performs well in study
- High Grade AV Block
- High-dose influenza vaccine better for solid organ transplant recipients
- Higher dietary acid load increases gestational diabetes risk
- Hispanic immigrant children less likely to experience adverse events
- House bill seeks to improve early detection, treatment of chronic kidney disease
- In DMARD-naïve patients with early RA, higher MTX dosage was not beneficial
- Indications for Hemodynamic Support in the Cath Lab
- Intervention reduces unnecessary PPI use in patients with upper GI bleeding
- Interventions may improve colonoscopy rates after positive fecal blood test
- Late-Breaking Clinical Trials
- Mavrilimumab, golimumab found effective, well-tolerated in patients with RA
- MDRO carriage ‘extensive’ in interconnected facilities
- Mechanical thrombectomy added to thrombolysis cost-effective for acute ischemic stroke
- Midday bright light therapy improves bipolar depression
- MR enterography accurately diagnoses active inflammation in children with IBD
- National Consumers League weighs in on contact lens act
- New Evidence, Ideas Abound at TCT 2017
- Obesity in type 2 diabetes increases major adverse CV event risk
- Obesity, hepatitis C epidemics drive ‘alarming’ increase in liver cancer incidence, mortality
- ObesityWeek symposium will feature talks on nutrition and metabolism
- One in four patients concurrently use opioids, benzodiazepines
- OrthAlign receives CE mark approval to include precision technologies for hip, knee replacement
- Pericardial Effusion
- Physical activity and cancer outcomes: Growing evidence for the oncologist
- Progress continues in the treatment of atherothrombosis
- Prolonged anesthesia duration linked to surgical complications
- Pushing the Boundaries of Intervention
- Rev360 expands EHR software to include imaging management
- Sacubitril/valsartan improves physical, social activity in HFrEF
- Should patients with unresectable HCC undergo systemic therapy?
- Stent graft system approved for treatment of AAA with hostile neck anatomy
- Strong grip may predict lower all-cause CVD mortality risk in diabetes
- Suicide most common in Americans living in rural areas
- The Asia Pacific CTO Algorithm: Think Global, Act Local
- The Evolution of Angioplasty
- The Take Home: VIVA
- Trial Scorecard: CANTOS
- Trial Scorecard: COMPASS
- Trial Scorecard: GUIDE-IT
- Trial Scorecard: LAACS
- Trial Scorecard: RE-DUAL PCI
- Trial Scorecard: REVEAL
- Trial Scorecard: Triple AXEL
- Trial Scorecard: VALIDATE-SWEDEHEART
- Trifascicular Block ECG Review
- Unrestricted coverage of many opioids persists
- Vision loss associated with decreased cognitive function
- Wanted: A Hybrid Peripheral CTO Algorithm